Spruce Biosciences, Inc. (SPRB)
OTCMKTS
· Delayed Price · Currency is USD
0.0720
+0.0005 (0.70%)
May 12, 2025, 3:56 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $3.15 million as of May 12, 2025. Its market cap has decreased by -89.09% in one year.
Market Cap
3.15M
Enterprise Value
-20.46M
Revenue
2.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from 378.48M to 3.15M, a decrease of -99.17%. That is a compound annual growth rate of -64.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 3.15M | -81.84% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | 564.33M | 49.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.62M |
| Tian'an Technology Group | 568.98M |
| CytoDyn | 497.14M |
| Glass House Brands | 478.11M |
| Elite Pharmaceuticals | 468.54M |
| Northwest Biotherapeutics | 395.18M |